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Abstract 
Halenaquinol sulfate, a p-hydroquinone sulfate obtained from a marine sponge, inhibited the activity of eukaryotic DNA polymerases in varying 
degrees; the K, values for DNA polymerases a, /3, 6 and E were 1.3, 80, 17.5 and 2.0 ,uM, respectively, whereas it was less effective against E. co/i 
DNA polymerase I. The inhibition occurred competitively with each of dATP and dTTP, but non-competitively with dCTP, dGTP and the template 
DNA. Thus, halenaquinol sulfate is demonstrated to be a potential inhibitor of DNA polymerases a and E, and be a useful tool for analyzing the 
dNTP binding sites of DNA polymerases. 
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1. Introduction 
Recent investigations have revealed that eukaryotic 
cells contain at least five types (a, /3, y, 6, and E) of DNA 
polymerase [l-3]. DNA polymerases 01 and 6 are re- 
quired for nuclear DNA replication, whereas DNA 
polymerase y participates in mitochondrial DNA repli- 
cation [l-2]. DNA polymerases /I and E have been impli- 
cated to be involved in DNA repair, but there are also 
reports suggesting that these enzymes are related to re- 
combination and DNA replication, respectively [l-3]. 
However, all function of eukaryotic DNA polymerases 
has not fully been elucidated. Previously, we found that 
aphidicolin is a selective inhibitor of both DNA polym- 
erase a and eukaryotic DNA replication, thereby reveal- 
ing that this polymerase is essential for DNA replication 
[4]. Thus, selective inhibitors of DNA polymerases are 
useful tools to distinguish DNA polymerases and to clar- 
ify their biological function [l]. However, there are very 
few inhibitors capable of distinguishing between DNA 
polymerases a, 6 and E. In the present study, we show 
that halenaquinol sulfate (Fig. I), which is obtained from 
the sponge Xestospongia sapra and which is known to be 
an inhibitor of protein tyrosine kinase [5] as well as an 
inhibitor of cell membrane fusion [6], is a novel, selective 
inhibitor of DNA polymerases a and E with the compet- 
itive mode of inhibition with respect o dATP and dTTP. 
*Corresponding author. Fax: (8 1) (824) 22 7059. 
2. Materials and methods 
2.1. Inhibitors 
Halenaquinol sulfate was purified from the sponge Xestospongia 
sapra, as described [7,8]. This compound was dissolved into ethanol and 
was directly diluted in the reaction mixture. Aphidicolin and heparin 
were obtained from Wako Pure Chemicals (Osaka, Japan) and 
Boehringer Mannheim (Mannheim, Germany), respectively. 
2.2. DNA polymerases 
DNA polymerase a was purified from calf thymus [9], human Raji 
cells [9] and Xenopus ovary [IO], as described previously. DNA polym- 
erase p was prepared from calf thymus [ll] and rat ovary [12], as 
described. DNA polymerase y was purified from human acute myelo- 
geneous leukemia cells, as described [13]. DNA polymerases 6 and E 
were purified from an extract of calf thymus using column chromatog- 
raphies with DEAE-cellulose, hydroxylapatite, Mono Q and Mono S, 
according to the procedure described by Weiser et al. [14] with modifi- 
cations (this procedure will be described in more detail elsewhere). E. 
coli DNA polymerase I and avian myeloblastosis virus reverse tran- 
scriptase were obtained from Takara (Kyoto, Japan). 
2.3. Assay for DNA polymerases 
Each DNA polymerase (0.014.05 units) was incubated with the 
indicated concentration of inhibitors in a standard reaction mixture at 
37°C for 30 min. The standard reaction mixture consisted of 25 mM 
Tris-HCI (pH 7.5), 50 mM KCl, 7 mM MgCl,, 10 PM each of dATP, 
dGTP and dTTP, 2.5 ,uM dCTP containing 1.0 pCi [‘H]dCTP, 0.1 
mg/ml activated calf thymus DNA, 0.4 mg/ml bovine serum albumin 
and 10% glycerol in a final volume of 25 ~1. For DNA polymerase y
and reverse transcriptase, the activated DNA and rH]dCTP were re- 
placed by poly(rA)$dT),, (40 ,@ml) and [‘H]dTTP, respectively. After 
incubation, DNA polymerase activity was determined by the incorpo- 
ration of radioactive deoxyribonucleoside 5’-monophosphates 
(dNMPs) into the acid-insoluble material, as described [9]. 
3. Results and discussion 
The inhibitory effect of halenaquinol sulfate on vari- 
ous kinds of DNA polymerase is summarized in Table 
1. Dose dependency of the inhibition is shown in Fig. 2. 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved, 
SSDI 0014-5793(94)00777-2 
250 
OH 0 
Fig. 1. Structure of halenaquinol sulfate. 
In the concentration range of up to 200 PM of halenaqui- 
no1 sulfate, the activity of all eukaryotic DNA polym- 
erases was suppressed to a certain extent, whereas only 
5% and 6% inhibition of the activity of E. coli DNA 
polymerase I and avian reverse transcriptase, respec- 
tively, resulted with the concentrations of 200 yM and 
20 PM, respectively (Fig. 2 and Table 1). Thus it is 
unlikely that halenaquinol sulfate acts simply as a chela- 
tor of divalent cations or a destructor of substrates, but 
this sensitivity reflects the characteristic property of each 
eukaryotic DNA polymerase. To obtain a half inhibi- 
tion, 5 and 7 ,uM concentrations of halenaquinol sulfate 
were required for DNA polymerases cc and E, respec- 
tively, while 100, 50 and 40 PM concentrations of hale- 
naquinol sulfate were needed for DNA polymerases p, 
y and 6, respectively (Fig. 2). Twenty micromolar con- 
centration of halenaquinol sulfate inhibited almost all of 
the DNA polymerase a and E activities, while the activity 
of polymerases /3, y and 6 decreased to 92%, 85% and 
75%, respectively, of the original level (Table 1). The 
sensitivity of DNA polymerases CI and /? to the inhibitor 
was unaltered regardless of animal or tissue species from 
which DNA polymerases were prepared (Table 1). 
Under the same assay conditions, 30 PM aphidicolin 
inhibited DNA polymerases ~1, 6 and E significantly, but 
not DNA polymerases /3 and y (Table 1), in accordance 
Table 1 
The inhibitory effects of halenaquinol sulfate, heparin and aphidicolin 
on various kinds of DNA polymerase 
DNA polymerase (Source) Inhibition of activity (%) 
Halenaquinol Heparin Aphidicolin 
sulfate (0.4 &ml) (30 PM) 
(20 PM) 
a (human Raji cell) 
cz (calf thymus) 
a (Xeflopus ovary) 
p (calf thymus) 
/? (rat ovary) 
y (human leukemia cell) 
6 (calf thymus) 
E (calf thymus) 
I (E. coli) 
Reverse transcriptase 
(avian myeloblastosis virus) 
92 
95 
93 
8 
5 
15 
26 
90 
2 
6 
95 94 
96 95 
94 85 
2 4 
3 4 
96 94 
93 94 
5 4 
_ _ 
M. Shioda et al. I FEBS Letters 350 (I 994) 249-252 
with the previous results [I 51. Remarkably, DNA polym- 
erase 6 was highly sensitive to aphidicolin, but not to 
halenaquinol sulfate (Table 1). 
As shown in Fig. 1, halenaquinol sulfate is a hydroqui- 
none containing an O-sulfate group. Compounds pos- 
sessing sulfate groups would be expected to inhibit some 
DNA polymerase activity, although other structural fea- 
tures are important in producing inhibition [ 16,171. 
Thus, we compared the inhibitory effect of halenaquinol 
sulfate on DNA polymerases with that of heparin, a 
polysaccharide containing sulfate groups, which is 
known to inhibit some eukaryotic DNA polymerases 
significantly [17,18]. Heparin (0.4 pg/ml) inhibited al- 
most all of the activity of DNA polymerases 01, 6 and E, 
but not of that of DNA polymerases /? and I (Table l), 
these results being consistent with previous ones [ 17,181. 
Thus, the sensitivity of DNA polymerases CX, p and E to 
heparin was similar to that to halenaquinol sulfate. On 
the other hand, DNA polymerase 6 is sensitive to hepa- 
rin, but relatively resistant o halenaquinol sulfate (Table 
1). This suggests that the mode of inhibition of DNA 
polymerases produced by halenaquinol sulfate differs 
from that of heparin. 
To elucidate the mode of inhibitory action of hale- 
naquinol sulfate on DNA polymerase CI, we examined 
the relationship between the concentration of each deox- 
yribonucleoside 5’-triphosphate (dNTP) and the effi- 
ciency of inhibition (Fig. 3). Lineweaver-Burk plots of 
the relationship clearly reveal that by varying the con- 
centration of either one of dATP and dTTP, the appar- 
ent K,,, value increased with an increase of the halenaqui- 
no1 sulfate concentration, whereas the apparent I’,,,.,, 
remained unchanged (Fig. 3). On the other hand, by 
Halenaquinol Sulfate (PM) 
Fig. 2. Dose dependency of the inhibitory effect of halenaquinol sulfate 
on eukaryotic DNA polymerase activity. DNA polymerase activity was 
assayed in the presence of the indicated concentration of halenaquinol 
sulfate, as described in the text. l , DNA polymerase a (calf thymus); 
O, DNA polymerase p (calf thymus); A, DNA polymerase y (human); 
A, DNA polymerase 6 (calf thymus); 0, DNA polymerase E (calf thy- 
mus); X, 
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l/dATP (l/pM) l/dCTP (l&M) 
l/dGTP (l/W) l/dTTP (~/FM) 
Fig. 3. Lineweaver-Burk plots showing the effects of the concentration 
of deoxyribonucleotides on inhibition of DNA polymerase a by hale- 
naquinol sulfate. DNA polymerase a (calf thymus) activity, expressed 
as pmol dNMP incorporated during 30 min, was determined in the 
presence of halenaquinol sulfate (0, 0 PM; l , 4 ,uM and A, 6 PM) as 
described in the text, except that the concentration of one (A, dATP; 
B, dCTP; C, dGTP and D, dTTP) of four dNTPs was varied in the 
presence of 20 PM each of the other three dNTPs. The results were 
shown by Lineweaver-Burk plots. The apparent K, values in the pres- 
ence of 0, 4 and 6 PM halenaquinol sulfate are 1.1, 3.6 and 10 PM, 
respectively, for dATP; 1.0, 1.0 and 1.1 PM, respectively, for dCTP, 
0.98, 1.0 and l.OpM, respectively, for dGTP; and I .l, 3.8 and 9.0 ,uM, 
respectively, for dTTP. 
varying the concentration of dCTP or dGTP, the I’,,, 
decreased, but the K,,, remained unchanged, with an in- 
crease of the halenaquinol sulfate concentration (Fig. 3). 
Next, the relationship between the amount of activated 
calf thymus DNA (template DNA) and the inhibition of 
the enzymatic activity was kinetically examined. It was 
found that the V,,, decreased, but the Km remained un- 
changed, with an increase of the template DNA concen- 
tration (data not shown). From these results, it is evident 
that halenaquinol sulfate inhibits DNA polymerase a 
competitively with only dATP and dTTP, but non-com- 
petitively with dCTP, dGTP and the template DNA. On 
the other hand, heparin inhibited DNA polymerase a 
Table 2 
The K, values of halenaquinol sulfate for DNA polymerases 
DNA KS? 
polymerase dATP 
(calf thymus) (uM) 
K 
Halenaquinol 
sulfate @M) 
KS? K 
dTTP Halenaquinol 
OtM) sulfate @M) 
8” 
1.1 1.2 1.0 1.3 
6.7 64.5 11.5 80.0 
6 1.4 16.2 1.1 17.5 
E 0.9 1.6 1.3 2.0 
The K, values of halenaquinol sulfate for DNA polymerases were deter- 
mined with respect to each of dATP and dTTP, as described in the 
legend to Fig. 3. 
non-competitively with dATP, dCTP, dGTP and dTTP, 
but competitively with the template DNA (data not 
shown), the results being essentially consistent with the 
previous ones [17]. This indicates that the nature of the 
inhibition produced by halenaquinol sulfate differs from 
that of heparin with respect to the mode of inhibitory 
action. At present, it remains unclear why halenaquinol 
sulfate, which is not a dNTP analogue, competes with 
dATP and dTTP. In this regard, it is notable that aphid- 
icolin, which is not a derivative of dNTPs as well, is a 
competitive inhibitor of DNA polymerase a with respect 
to dCTP [19,20]. In contrast to halenaquinol sulfate, 
aphidicolin does not compete with dATP and dTTP 
POI. 
The same mode of inhibitory action of halenaquinol 
sulfate as that for DNA polymerase a was observed for 
DNA polymerases /I, 6 and E (data not shown). The Ki 
values of halenaquinol sulfate for these DNA polym- 
erases (Table 2) show that halenaquinol sulfate inhibits 
eukaryotic DNA polymerases differentially and it is a 
potent inhibitor of DNA polymerases c1 and E. 
DNA polymerases a, /I and y have been distinguished 
by selective inhibitors such as aphidicolin, dideoxyTTP 
and N-ethylmaleimide [15]. It has been reported that 
butylphenyl-dGTP and buthylamilino-dATP inhibit 
DNA polymerases efficiently, 6 E [21-231. 
the hand, inhibits 
polymerases efficiently, a E [23,24]. 
from sensitivity the of 
action, sulfate a type inhibitor 
eukaryotic polymerases. use halenaqui- 
sulfate offer opportunity distinguish 
tween polymerase and other DNA 
The described this suggest 
the and binding in polym- 
a, and are from binding for 
other dNTPs. halenaquinol is 
for the binding in 
of polymerase 
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